ACLARION INC Missed Consensus Estimates

ACLARION INC (ACON) reported a loss of $1.12 per share on revenue of $0.03 million for the second quarter ended June 2026. The consensus estimate was a loss of $1.05 per share on revenue of $0.03 million. The company missed consensus estimates by 6.67% while revenue grew 31.58% on a year-over-year basis.

Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA.